Ylä-Herttuala S - Search Results

1

Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease.

Erkkilä AT, Närvänen O, Lehto S, Uusitupa MI, Ylä-Herttuala S. Erkkilä AT, et al. Atherosclerosis. 2005 Nov;183(1):157-62. doi: 10.1016/j.atherosclerosis.2005.02.026. Epub 2005 Apr 14. Atherosclerosis. 2005. PMID: 16216595

2

Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Salonen JT, et al. Lancet. 1992 Apr 11;339(8798):883-7. doi: 10.1016/0140-6736(92)90926-t. Lancet. 1992. PMID: 1348295 Free article.

3

Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.

Uusitupa MI, Niskanen L, Luoma J, Vilja P, Mercuri M, Rauramaa R, Ylä-Herttuala S. Uusitupa MI, et al. Arterioscler Thromb Vasc Biol. 1996 Oct;16(10):1236-42. doi: 10.1161/01.atv.16.10.1236. Arterioscler Thromb Vasc Biol. 1996. PMID: 8857919 Clinical Trial.

4

Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.

Leppänen P, Luoma JS, Hofker MH, Havekes LM, Ylä-Herttuala S. Leppänen P, et al. Atherosclerosis. 1998 Jan;136(1):147-52. doi: 10.1016/s0021-9150(97)00196-2. Atherosclerosis. 1998. PMID: 9544741

5

Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL.

Heikkinen AM, Niskanen L, Ylä-Herttuala S, Luoma J, Tuppurainen MT, Komulainen M, Saarikoski S. Heikkinen AM, et al. Maturitas. 1998 Jun 3;29(2):155-61. doi: 10.1016/s0378-5122(98)00002-4. Maturitas. 1998. PMID: 9651905 Clinical Trial.

6

Is oxidized low-density lipoprotein present in vivo?

Ylä-Herttuala S. Ylä-Herttuala S. Curr Opin Lipidol. 1998 Aug;9(4):337-44. doi: 10.1097/00041433-199808000-00009. Curr Opin Lipidol. 1998. PMID: 9739490 Review.

7

The level of autoantibodies against oxidized LDL is not associated with the presence of coronary heart disease or diabetic kidney disease in patients with non-insulin-dependent diabetes mellitus.

Leinonen JS, Rantalaiho V, Laippala P, Wirta O, Pasternack A, Alho H, Jaakkola O, Ylä-Herttuala S, Koivula T, Lehtimäki T. Leinonen JS, et al. Free Radic Res. 1998 Aug;29(2):137-41. Free Radic Res. 1998. PMID: 9790515

8

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

Lehtimäki T, Lehtinen S, Solakivi T, Nikkilä M, Jaakkola O, Jokela H, Ylä-Herttuala S, Luoma JS, Koivula T, Nikkari T. Lehtimäki T, et al. Arterioscler Thromb Vasc Biol. 1999 Jan;19(1):23-7. doi: 10.1161/01.atv.19.1.23. Arterioscler Thromb Vasc Biol. 1999. PMID: 9888862

9

Oxidized LDL and atherogenesis.

Ylä-Herttuala S. Ylä-Herttuala S. Ann N Y Acad Sci. 1999 Jun 30;874:134-7. doi: 10.1111/j.1749-6632.1999.tb09231.x. Ann N Y Acad Sci. 1999. PMID: 10415527 Review.

10

Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein.

Viita H, Närvänen O, Ylä-Herttuala S. Viita H, et al. Life Sci. 1999;65(8):783-93. doi: 10.1016/s0024-3205(99)00305-7. Life Sci. 1999. PMID: 10466744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

766 results

Search Page

Filters